SAN FRANCISCO (MarketWatch) -- Amgen Inc. after Wednesday's closing bell introduced Amgen Oncology Assistance, a financial assistance program that will include a cap on out-of-pocket co-payments for ...
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha ® (evolocumab). This follows ...
Clinician-led engagement outperforms non-clinical call-center models, with “nurse ambassador” programs enabling escalation, ...
Please provide your email address to receive an email when new articles are posted on . Evolocumab will be made available to eligible patients via a new direct-to-consumer program. The PCSK9 inhibitor ...
While some states ban insurers from using copay accumulator programs, oversight has stalled at the federal level.
Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results